Convergence Investment Partners, LLC Pacira Bio Sciences, Inc. Transaction History
Convergence Investment Partners, LLC
- $431 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
49.8MCall Options Held
1.03MPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$185 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$122 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$75.4 Million0.15% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$52.1 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.99MShares$46 Million0.06% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.06B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...